SCHEMBL9366147

SCHEMBL9366147

CCCCCCCCCCCCOc1ccc(C(=O)Nc2cc(C(=O)NCCCC)ccc2SCC)cc1

nearest known ligand 0.83

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ACAT1 P24752 1/20 0.83
PLK1 P53350 4/20 0.53
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
NR1H4 Q96RI1 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9361223 1.00 ACAT1 (0.83) ACAT1PLK1MAPK1HTTSMN1; SMN2
SCHEMBL9366207 1.00 ACAT1 (0.83) ACAT1PLK1MAPK1HTTSMN1; SMN2
SCHEMBL9361706 0.93 ACAT1 (0.76) ACAT1PLK1MAPK1HTTSMN1; SMN2
SCHEMBL9365128 0.93 ACAT1 (0.71) ACAT1PLK1NR1H4
SCHEMBL9361674 0.93 ACAT1 (0.72) ACAT1PLK1MAPK1HTTSMN1; SMN2
SCHEMBL9362304 0.92 ACAT1 (0.74) ACAT1PLK1MAPK1HTTSMN1; SMN2
SCHEMBL9361191 0.91 ACAT1 (0.70) ACAT1PLK1MAPK1HTTSMN1; SMN2
SCHEMBL9361027 0.91 ACAT1 (1.00) ACAT1PLK1MAPK1HTTSMN1; SMN2
SCHEMBL9361036 0.91 ACAT1 (1.00) ACAT1PLK1MAPK1HTTSMN1; SMN2
SCHEMBL9365235 0.91 ACAT1 (1.00) ACAT1PLK1MAPK1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0424194-B1 Benzanilide derivatives and their use as anti-atherosclerotic agents RHONE POULENC SANTE (FR) 1994-08-31 EP disclosed
US-5159114-A Anticholesterol agents RHONE-POULENC SANTE (FR) 1992-10-27 US disclosed
EP-0424194-A2 Benzanilide derivatives and their use as anti-atherosclerotic agents RHONE-POULENC SANTE (FR) 1991-04-24 EP disclosed